Abstract: Alzheimer's disease (AD) is related to increasing age. It is mainly characterized by progressive neurodegenerative disease, which damages memory and cognitive function. Natural products offer many options to reduce the progress and symptoms of many kinds of diseases, including AD. Meanwhile, natural compound structures, including lignans, flavonoids, tannins, polyphenols, triterpenes, sterols, and alkaloids, have antiinflammatory, antioxidant, anti-amyloidogenic, and anticholinesterase activities. In this review, we summarize the pathogenesis and targets for treatment of AD. We also present several medicinal plants and isolated compounds that are used for preventing and reducing symptoms of AD.
Introduction
Alzheimer's disease (AD) is a disease related to aging. It is neurodegenerative disease that leads to memory loss and impaired cognitive function. The reports of the World Health Organization in 2012 showed that over 35.6 million people in the world have dementia, and about 60%-70% of this population has AD. The same report also predicted that the number of people with dementia, and those with AD, shall continue to increase [1] .
Pathogenesis of Alzheimer's disease
Until now, the pathogenesis of AD is not yet completely understood. The genetic susceptibility and environmental factors are responsible for late onset sporadic AD, which is the most common form of the disease. Many studies have attempted to understand the disease mechanism and develop a disease-modifying drug. Two main factors are responsible for the development of AD: β-amyloid protein and abnormal tau protein, or both of them. AD is characteristized by the overproduction of β-amyloid proteins (Aβ) and hyperphosphorylated Tau protein, which can lead to the loss of synaptic connections and neurons in the hippocampus and cerebral cortex, a decline in cognitive function, and dementia [2] . The accumulation of β-amyloid protein and neurofibrillary tangles have been shown in AD patients. The overproduction and accumulation of Aβ lead to oxidation, lipid peroxidation, inflammation, disturbance of cell functions, and apoptosis and formation of neurofibrillary tangles [3] . The tau protein is hyperphosphorylated, which leads to the formation of tangles deposited in the hippocampus and, ultimately, to cell death [4] . Many biochemical changes within cells, such as oxidative stress, inflammation, metabolic disturbances, disruption of Ca 2+ homeostasis, and the accumulation of unfolded/ mis-folded proteins, have been demonstrated to induce neuronal cell death in AD patients [5] . The two mechanisms involved in AD are oxidative damage and inflammatory process, and both of these have been studied well in the literature.
Acetylcholinesterase inhibitor for the treatment of Alzheimer's disease
Cholinergic hypothesis is an important hypothesis that is used to explain the pathogenesis of AD. This hypothesis explains that AD is caused by a decrease in neurotransmitter acetylcholine (Ach). Many drugs used in the treatment of AD are based on cholinergic hypothesis [6] . ACh, serotonin, and norepinephrine are neurotransmitter deficits in the brain that occur because of cell death. Many studies have shown that a low level of neurotransmitters in a cholinergic system is responsible for cognitive decline and memory loss in AD patients [6] [7] [8] [9] . Acetylcholinesterase (AChE) is a main enzyme that degrades the ACh neurotransmitter. Various therapeutic strategies elevate ACh neurotransmitter levels, then increase cholinergic transmission by inhibiting ACh hydrolysis with AChE inhibitors, stimulating nicotinic and muscarinic receptors or using cholinomimetic substances [9] . Drugs such as galantamine, tacrine, donepezil, metrifonate or rivastigmine inhibit AChE, augment the level of Ach, and improves cholinergic transmission. These drugs have been used to alleviate the symptoms of AD, which are caused by the degeneration of cholinergic neurons and injured transmission. However, the inhibition of AChE has not been very effective in the treatment of Alzheimer [9] . AChE inhibitors have many side effects, such as nausea, vomiting, diarrhea, abdominal pain, dyspepsia, and skin rash [8] . Tacrine has also been found to induce hepatotoxicity in clinical trials [10] . Physostigmine was taken out from the drug market due to many disadvantages. Therefore, finding new AChE inhibitors, which may be found in medicinal plant resources, with less adverse effects is important.
Antioxidants for the treatment of Alzheimer's disease
Many studies have shown that brain tissues in AD patients are subjected to oxidative stress. Oxidative stress leads to protein oxidation, lipid oxidation, DNA oxidation, and glycoxidation [11] . The imbalance in the production of reactive oxygen species (ROS) and antioxidative defense system, which is responsible for ROS removal, is characterized by oxidative stress. It leads to the age-related neurodegeneration and cognitive decline [12] . ROS, such as superoxide anion radical (O 2˙− ), hydrogen peroxide (H 2 O 2 ), hydroxyl radical (˙OH), singlet oxygen ( 1 O 2 ), alkoxyl radicals (RO˙), peroxyl radicals (ROO˙), and reactive nitrogen species (RNS), such as peroxynitrites (ONOO −), enrich many human degenerative diseases [13] . Oxidative stress occurs when ROS and RNS levels exceed the removal capacity of the antioxidant system and cause cell metabolism dysfunction, leading to several pathological conditions or aging [14] . High levels of protein oxidation, lipid oxidation, DNA oxidation, and glycoxidation are the main manifestations during the course of AD [15] . The imbalance of ROS levels and antioxidative defense system typically causes oxidative stress in AD patients. Hence, antioxidant treatment is a promising strategy for inhibiting disease progression.
A recent study has shown the link between antioxidant intake and reduced symptoms of dementia [16] . Treatment with antioxidants, such as those found n vitamin E, vitamin C, selegiline, estrogen, and Ginkgo biloba, may inhibit the development of AD [17] . Furthermore, some medicinal plants with antioxidant activities also exhibit potential for AD treatment. Jung et al. have reported that three major alkaloids in Coptidis rhizoma, including groenlandicine, berberine, and palmatine, can potentially exhibit anti-AD effects by inhibiting AChE activity and Aβ accumulation, and also present antioxidant capacities to inhibit ROS and RNS levels [13] . Silibinin, an isolated flavonoid from Silybum marianum, also has an antioxidant property. Silibinin has been shown to prevent memory impairment and oxidative damage induced by Aβ in mice model, making it a potential agent for AD treatment [18] . Therefore, further studies related to medicinal plants that have antioxidant properties for the treatment of AD should be conducted.
Amyloid hypothesis and Alzheimer drugs targeting β-amyloid
The amyloid hypothesis was developed in 1991. It states that the extracellular β-amyloid deposits are the main cause of AD [19] . β-amyloid, a short fragment of the amyloid precursor protein (APP), is a product of a processing error of the APP in the brain. The accumulated clusters of β-amyloid proteins are called amyloid plaques. The amyloid plaques in the brain provoke the destruction of neuronal cells and leads to AD. APP is a long protein consisting of up to 771 amino acids. APP is cut by two different enzymes leading to the generation of β-amyloid [20] . The first β-secretase cuts the APP and then the second gamma-secretase enzyme cuts one more time to generate β-amyloid, which may have a length of 38, 40, or 42 amino acids. The length of 42 amino acids causes β-amyloid to be chemically stickier than the other lengths, thus leading to clumps and the formation of plaques.
β-Amyloid plaques also provoke the formation of tangles of tau proteins. These tangles also damage the neuronal cells, which lead to dementia [21] . The formation of β-amyloid plaques also leads to oxidative stress in the neurons, which in turn, aggravates the development of AD [22] . Aβ has several isoforms, but the form of 42 amino acids has been mainly found in amyloid plaques. Other isoforms have also been found, such as Aβ 1−40 and Aβ 25−35 . Many studies have used Aβ 1−42 and Aβ 25−35 to produce oxidative stress to study the neuroprotection of natural products using different cell lines [23] . When neuronal cell is exposed to Aβ, this leads to increased ROS production, mitochondria dysfunction, and apoptosis as well as the down regulation of antioxidant genes, leading to neuronal cell dysfunction and worsened AD symptoms [24] . APOE4, an isoform of apolipoprotein, is a major genetic risk factor for AD. This APOE4 may induce β-amyloid accumulation in the brain [19] . As amyloid plaques are increased in AD patients. Hence, researchers have proposed that drugs preventing β-amyloid accumulation may be a potential treatment for AD. PBT2, a drug candidate, is a second-generation of eighthydroxyquinoline analog for AD. PBT2 has been shown in animal models to effectively detoxify Aβ and increase the clearance of β-amyloid [25] . In a clinical trial, PBT2 at a dose of 250 mg also decreased levels of Aβ 1−42 in the brain [26] . Therefore, drugs that can inhibit β-amyloid accumulation may be a strategy for AD treatment.
The β-amyloid plaques in the brain damages neuronal cells by inducing inflammatory reaction. AD is also characterized by neuroinflammation features. Cytokines, such as interleukin-1, interleukin-6 (IL-6), and tumor necrosis factor alpha, have been shown to play a role in the neuroinflammatory process. These cytokines' expressions are increased by β-amyloid peptide. In return, these cytokines estimate the accumulation of β-amyloid peptide [27] . Some researchers suggested that these cytokines may play an important role in the progression of AD [28] . The prolonged use of non-steroidal anti-inflammatory drugs (NSAIDs) has reduced the development of AD and delayed the onset of the disease [29] . The mechanism of NSAIDs in decreasing symptoms of Alzheimer may be related to the inhibition of the cyclooxygenases (COX) and the activation of peroxisome proliferator-activated receptor γ (PPARγ) [29] . NSAIDs have been shown to suppress the expression of COX, which in turn, stimulates the synthesis of prostaglandins and decreases the production of cytokines [30] . An in vivo model of transgenic mice with AD and in vitro model of cell cultures of peripheral, glial, and neuronal NSAIDs, such as ibuprofen, indomethacin, and sulindac, decrease the level of Aβ [29] . However, the beneficial effect of NSAIDs in AD treatment are still being discussed due to the limited evidence presented [31] .
Herbal medicine for the treatment of Alzheimer's disease
Medicinal plants have been shown to decrease the progress and symptoms of various diseases, including AD [32] . Many studies have been conducted to investigate the effects of total medicinal plant extracts on AD as well as to isolate and identify the active compounds involved [33] . Many compounds, including lignans, flavonoids, tannins, polyphenols, triterpenes, sterols, and alkaloids, have shown various beneficial pharmacological activities, such as antiinflammatory, anti-amyloidogenic, anticholinesterase, and antioxidant [32] . Some compounds, such as aged garlic extract, curcumin, melatonin, resveratrol, Ginkgo biloba extract, green tea, and vitamins C and E, have been used in patients with AD and yielded positive results [34] [35] [36] . Below, we summarize information on some medicinal plants and isolated compounds that are used for the treatment of AD.
Medicinal plants used for the treatment of Alzheimer's disease

Curcuma longa
Turmeric of Curcuma longa is a rhizomatous perennial plant of the ginger family, Zingiberaceae. The active compounds are water-insoluble curcuminoids, including curcumin, demethoxycurcumin, and bis-demethoxycurcumin [37] . Curcumin is the main curcuminoid and it is responsible for the yellow color of the turmeric root [38] . Curcumin has anti-inflammatory, antioxidant, antitumor, antibacterial activities, among others [39, 40] . A previous review has shown that curcumin may be a promising compound for the treatment of AD [41] . According to another study, when aged mice with β-amyloid plaque accumulation were fed with curcumin, this reduced the amount of plaque deposition [42] . Curcumin can decrease oxidative damage status in the brain [43] . In an Alzheimer transgenic mouse model, curcumin has been shown to reverse the β-amyloid pathology [44, 45] . Some symptoms of AD were also reduced by curcumin's antioxidant and anti-inflammatory properties [45] . In vitro curcumin may inhibit lipid peroxidation and neutralize ROS levels, making it even more potent than vitamin E [46, 47] . Curcumin (with a dose of 5-10 μM) protected PC12 cells against Aβ-induced neurotoxicity by inhibiting oxidative damage and tau hyperphosphorylation [42] . In a clinical trial, curcumin has shown several beneficial effects on healthy middle aged people, including lowering the plasma β-amyloid protein concentrations [48] . More experiments are needed to evaluate the exact mechanism of C. longa.
Bacopa monnieri
Bacopa monnieri is commonly used in traditional medicine as a nerve tonic, diuretic, and a cardiotonic agent as well as for the treatment of asthma and rheumatism. It also applied for epilepsy, insomnia [49] . The main compounds of B. monnieri are saponins and triterpenoids. These compounds, such as bacopasides III, bacopasides IV, bacopasides V, bacosides A, bacosides B, bacosaponins A, bacosaponins B, and bacosaponins C, have been isolated from B. monnieri. The presence of some saponin glycosides, such as jujubogenin bisdesmosides bacopasaponins D, bacopasaponins E, and bacopasaponins F, in B. monnieri has also been reported. Furthermore, other compounds, including alkaloids, sterols, betulic acid, polyphenols, and sulfhydryl, which have antioxidant activities, have also been found in B. monnieri [50] . Traditional medicine has used B. monnieri for improving memory and cognitive function [51] . Many studies related to neuropharmacological effects and nootropic action of B. monnieri extracts have been conducted extensively [52] . In the hippocampus, B. monnieri augments protein kinase activity, which provides a nootropic action [53] . In an animal Alzheimer model, rats fed with B. monnieri extract showed decreased cholinergic degeneration and exhibited cognition-enhancing effect [54] . Another study reported that B. monnieri inhibited the AChE activity and increased ACh levels [55] . Moreover, B. monnieri extracts also protected neuronal cells from damages caused by β-amyloids. Moreover, neuronal cells treated with B. monnieri extract exhibited lower levels of ROS, suggesting that B. monnieri reduced intracellular oxidative stress [56] . A clinical trial of AD patients showed that the polyherbal formulation containing B. monnieri extract effectively improved the cognitive functions and decreased the level of inflammation and oxidative stress in patients [57] . Nevertheless, detailed investigations are needed to further assess the potential neuroprotective action of B. monnieri against AD.
Convolvulus pluricaulis
The phytochemicals of Convolvulus pluricaulis reveal that it may contain active compounds, such as triterpenoids, flavonol glycosides, anthocyanins, and steroids. They provide the nootropic and memory-enhancing activity for C. pluricaulis [58] . Another study reported that C. pluricaulis may calm the nerves by regulating stress hormone, adrenaline, and cortisol levels in the body [58] . Traditional medicines have used C. pluricaulis for nervous system-related diseases, including stress, anxiety, mental fatigue, and insomnia [59] . Learning and memory in rats were significantly enhanced by feeding them with the ethanolic extract of C. pluricaulis and its ethyl acetate and water fractions [60] . The oral administration of C. pluricaulis also alleviated the neurotoxic effect of scopolamine by reducing the induction of protein and mRNA levels of tau and AβPP [61] . Unfortunately, no clinical data exist on the effects of C. pluricaulis on AD patients. Further investigations are thus needed to explore the potential favorable effects of C. pluricaulis on AD treatment.
Centella asiatica
Traditional medicines have used Centella asiatica for rejuvenating the neuronal cells. It has also been used for increasing intelligence, longevity, and memory [52] . Asiatic acid and asiaticoside have been isolated from C. asiatica, and these compounds have shown the ability to reduce H 2 O 2 -induced cell cytotoxicity, decrease free radical levels, and inhibit β-amyloid cell damages in vitro. C. asiatica extracts reduced the β-amyloid pathology and decreased the oxidative stress response in the brains of a mice model of AD [62] . It has already been reported that C. asiatica ethanol extracts can protect neuronal cells against Aβ 1−40 -induced neurotoxicity. C. asiatica can also decrease ROS production and modulate the antioxidative defense system in cells by enhancing the activities of superoxide dismutase, catalase, glutathione peroxidase, glutathione reductase, and levels of glutathione and glutathione disulfide [63] . These activities suggest the important role of C. asiatica for the prevention and treatment of AD [64] .
Ginkgo biloba
Ginkgo biloba leaves have been used in traditional medicine as an agent for improving memory and age-related deterioration. The phytochemicals of Ginkgo biloba leaf extracts contain flavonoids, organic acids, and terenoids, which provide neuroprotective activity. The protective mechanism of Ginkgo biloba leaf extracts against β-amyloid has been shown to induce cytotoxicity and may be related to the capacity to scavenge free radicals, reduce mitochondrial dysfunction, activate JNK and ERK pathways, and prevent neuronal apoptosis. Bilobalide is a principal terpenoid compound isolated from Ginkgo biloba leaves; it has potent protective effects on neurons and Schwann cells [65] . Bilobalide has been shown to reduce the expression of p53, Bax, and caspase-3 proteins as well as inhibite ROS-induced apoptosis in PC12 cells [66] . Bilobalide also stimulated neurogenesis and synaptogenesis by increasing the levels of transcription factor phosphorylated CREB and neurotrophin BDNF in neuronal cells [67] . Furthermore, the clinical trial of marketing a dietary supplement containing Ginkgo biloba extract was beneficial in treating cognitive decline in the aging process and in the early stages of AD [68] .
Zingiber officinaleis
Zingiber officinaleis has been widely used in food supplements as extracts or as ingredients of ginger tea. Principal compounds, such as gingerols, shagols, bisabolene, zingiberene, and monoterpenes, have been isolated from Z. officinaleis [69] . In vitro assays have shown the AChE inhibitory activity of Z. officinaleis. Inhibiting the AChE enzyme increases ACh levels in synapses, augments the activity of cholinergic pathways, and enhances cognitive functions in AD patients. Furthermore, Z. officinaleis has the ability to inhibit lipid peroxidation and provide the protective effect against AD. An in vivo assay has reported reduced levels of lipid peroxidation in rats fed with Z. officinaleis extract. The mechanism may be explained by the ability of Z. officinaleis extract to reduce the overstimulation of N-methyl-D-aspartate (NMDA) receptors and prevent the formation of free radicals [70] .
Allium sativum
Allium sativum has been used in food and medicinal supplements. Borek et al. have investigated the neuroprotective effect of the aged garlic extract in a Tg2576 mice model, in which mice fed with aged garlic extracts exhibited enhanced memory in the hippocampal region [71] . The mechanism has scavenged the free radicals; increased enzyme antioxidants, such as superoxide dismutase, catalase, glutathione peroxidase, and glutathione levels; inhibited lipid peroxidation level; and reduced inflammatory prostaglandins [72] . Moreover, aged garlic extracts inhibited 3-hydroxy-3-methylglutaryl-CoA reductase and reduced cholesterol synthesis. Aged garlic extracts can also protect neurons from β-amyloid neurotoxicity and apoptosis, preventing cognitive decline, ischemia or reperfusion-related neuronal death, and enhancing learning and memory retention [73] . A recent study has reported that aged garlic extracts were useful in enhancing the short-term recognition memory and reducing the neuroinflammation in Aβ-induced rats [74] as well as in attenuating neuroinflammatory responses in microglial cells [75] .
Others
Some natural product compounds have also been isolated from medicinal plants for the treatment of AD.
Quercetin
Quercetin is a flavonoid compound found in a wide variety of medicinal plants, such as apples, onions, berries, green tea, and red wine. Quercetin has a strong antioxidant activity by scavenging ROS [76] . In addition, it has other beneficial properties, including anticancer, antiviral, antiinflammatory, and antiamyloidogenic properties [77, 78] . Quercetin at a dose of 10 μM has shown antiamyloidogenic activity by inhibiting the accumulation of β-amyloids [79] . Quercetin also reduced the Aβ-induced apoptosis in neuronal cells. However, at a higher dose (40 μM), quercetin may induce cytotoxicity [80] . A recent study has shown that nanoencapsulated quercetin in zein nanoparticles significantly improved cognition and memory impairments on senescence-accelerated P8 mice. The mechanism may be related to the decreased expression of the hippocampal astrocyte marker GFAP [81] .
Epigallocatechin-3-gallate
Epigallocatechin-3-gallate is a flavonoid-type catechin found in Camellia sinensis. Epigallocatechin-3-gallate has potent antioxidant activity, and many studies have investigated the effects of epigallocatechin-3-gallate on various diseases, including cancer and cardiovascular and neurodegenerative diseases [82] . Epigallocatechin-3-gallate has been shown to increase glutathione peroxidase activity, inhibit the AChE activity and inhibit NO metabolite formation and ROS generation in streptozotocin-induced dementia in mice [83] . Epigallocatechin-3-gallate also increased memory formation and inhibited γ-secretase enzyme activity in mutant PS2 Alzheimer mice [84] . Furthermore, epigallocatechin-3-gallate prevented LPS-induced memory loss and apoptosis by decreasing amyloid precursor protein expression, inhibiting beta-site APP cleaving enzyme 1 activity, and reducing β-amyloid accumulation. Moreover, it has also been shown to reduce the expression of inflammatory factors, such as tumor necrosis factor-α (TNF-α), interleukin 1β, IL-6, inducible nitric oxide synthase (iNOS), cyclooxygenase-2 (COX-2), soluble intracellular adhesion, and molecule-1 macrophage colony-stimulating factor, and to prevent astrocyte activation in neuronal cells [85, 86] . Epigallocatechin-3-gallate has also been shown to reduce Aβ accumulation and elevate neprilysin enzyme expression, which is the rate-limiting degradation enzyme of Aβ in senescence-accelerated P8 mice [87] .
Berberine
Berberine is a quaternary ammonium salt and a type of isoquinoline alkaloids, isolated from Coptis chinensis [88] . Berberine has many biological activities, such as antioxidant activity, inhibition of AChE and butyrylcholinesterase, monoamine oxidase, and cholesterol-lowering activity [88] . Tg mice fed with berberine at a dose of 100 mg/kg via oral administration showed significantly increasing learning and spatial memory [89] . BV2 microglia cells treated with berberine significantly reduced the β-amyloid-induced expressions of IL-6, COX-2, and iNOS [90] . In addition, berberine also strongly reduced the expression of NF-κB by inhibiting the PI3K/protein kinase B and MAPK pathways [91] . A recent study has shown that berberine can significantly ameliorate memory impairment, reduce Aβ and APP levels, reduce Aβ plaque deposition in the hippocampus [92] , and prevent the increase of AChE activity [93] .
Resveratrol
Resveratrol is a polyphenolic compound belonging to the group stilbenes. Resveratrol can be found in red wine, nuts, and the skin of grapes and other fruits [94] . Many studies have shown that it has anti-cancer, antiinflammatory, antioxidant, and protective cardiovascular properties, can lower blood glucose levels, and neuroprotective effects [95] . Resveratrol has a potent antioxidant activity by scavenging ROS, increasing gluthatione levels, and improving the endogenous antioxidants [96] . Resveratrol can also reduce the level of β-amyloids by inducing the non-amyloidogenic cleavage of APP and enhancing the clearance of β-amyloid [95] . Resveratrol (15, 45 , and 135 mg/kg) also inhibited AChE activity in neuronal cells [97] . A randomized, double-blind, placebo-controlled trial of resveratrol for AD provided evidence that resveratrol is safe, well-tolerated, and has the ability to reduce CSF Aβ40 and plasma Aβ40 levels [98] . Recently, He et al. [99] provided evidence proving that resveratrol protects against hyperphosphorylation and/or mediates dephosphorylation of the tau protein. Moroever, they found that resveratrol ameliorated the deleterious effects in a rat model for AD by alleviating cholinergic pathways, thus reducing oxidative stress and improving spatial memory [100] . Evidence that resveratrol may modulate neuroinflammation and induces adaptive immunity by the activation of SIRT1 has also been presented [101] .
Huperzine A
Huperzine A is a sesquiterpene alkaloid group found in Huperzia serrate. Traditional medicine has used Huperzine A for the treatment of fever and swelling. H. serrate extract can also be used as a food supplement for improving memory [102] . Huperzine A has a strong effect on the inhibition of AChE. Its mechanism is similar to those of rivastigmine, donepezil, and galantamine, which have been used for AD treatment. The new tacrine-Huperzine A combination (called Huprines) is a potent AChE inhibitors that can significantly reduce Aβ-induced memory injury [103] . Clinical trials have shown that huperzine A has very low minimal adverse reactions, such as gastroenteric symptoms, dizziness, headaches, nausea, and reduced heart rate. This is an advantage of huperzine A compared with other drug AChE inhibitors for AD treatment [102] . Huperzine A can potentially inhibit several apoptotic factors, including caspase-3, Bax, and p53. Huperzine A also regulated the expression and secretion of the nerve growth factor [104] . Huperzine A enhanced learning capacity and memory in Tg mice in a Morris water maze test. The mechanism can be explained by the inhibition of PKC/MAPK, γ-secretases, and BACE as well as in the increase of phospho GSK-3 [105] . Huperzine A also reduced the β-amyloid plaques and oligomeric A amount in the cortex and hippocampus [106] . Moreover, huperzine A can inhibit the NMDA receptor and potassium chanel in the brain [107] . A phase II trial of huperzine A in mild to moderate AD showed that huperzine A 200 μg did not demonstrate cognitive benefits; however, the huperzine A 400 μg can improve the Alzheimer's Disease Assessment Scale-cognitive [108] . Still, further studies are needed to fully elucidate the efficiency of huperzine A against AD.
Rosmarinic acid
Rosmarinic acid is a polyphenol-type carboxylic acid existed in many Lamiaceae speies [109] . Rosmarinic acid has many pharmacological activities, such as antioxidant, antibacterial, anti-inflammatory, anticancer, antiviral, and neuroprotective effects [110] . Rosmarinic acid may significantly prevent β-amyloid-induced memory loss, the mechanism of which may be attributed to its capacity to inhibit NF-κB and TNF-α expressions [111] . Rosmarinic acid has also been shown to protect neuronal PC12 cells to avoid beta-amyloid-induced cytotoxicity. Furthermore, it may decrease the hyperphosphorylation of the tau protein. Inhibiting apoptotic pathways by rosmarinic acid may be explained due to its capacity to inhibit ROS formation, caspase-3 activation, and DNA fragmentation [112] . Rosmarinic acid may also prevent locomotor activity, short-term spatial memory, and biochemical alterations of brain tissue found in a rat model of AD by reducing lipid peroxidation and inflammatory process [113] . Clinical trial studies are needed to further demonstrate the efficiency of rosmarinic acid against AD.
Luteolin
Luteolin is a flavonoid compound found in many medicinal plants, such as Magnoliophyta, Pteridophyta, Bryophyta, and Pinophyta [114] . Luteolin has been shown to have many biological activities, such as anti-inflammatory, antioxidant, anticancer, antimicrobial, and neuroprotective effects [115] . Luteolin can also reduce the zinc-induced hyperphosphorylation of the tau protein, the mechanism of which may be explained by its antioxidant activity and ability to regulate the tau phosphatase/ kinase system [116] . Furthermore, luteolin can decrease the expression of amyloid precursor protein and reduced the formation of β-amyloids [117] . Luteolin can also also inhibit apoptosis by decreasing intracellular ROS generation; improving antioxidant endogenous system; such as augmenting SOD, CAT and GPx activities; and activating the NRF2 pathway [118] . Luteolin has also been shown to have the ability to relieve the cognitive dysfunction, improve significantly antioxidant system, decrease the lipid peroxide production, and inhibit inflammatory reaction in the brain tissue of rats induced by chronic cerebral hypoperfusion [119] . In another study, luteolin also improved the cognition function and memory on a streptozotocin-induced AD rat model [120] . Despite these studies, further clinical trial data are needed to confirm the protective effects of luteolin against AD.
Conclusions
Many valuable medicinal plants can be applied to reduce dementia and treat AD. The main chemical compounds, such as flavonoids and alkaloids, have been shown to have strong effects against AD. Therefore, studying medicinal plants in depth and finding new active compounds against AD is necessary.
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